Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting

Supportive Care in Cancer

Volumn 21, Issue 10, 2013, Pages 2759-2767

  Molassiotis, A ^a,b   Stamataki, Z ^a,c   Kontopantelis, E ^d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^c CHRISTIE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cancer; Chemotherapy; Model; Nausea; Prediction; Risk factors; Vomiting

Indexed keywords

ANTHRACYCLINE;

ADULT; AGE; ANXIETY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; DEMOGRAPHY; DIGESTIVE SYSTEM CANCER; DISTRESS SYNDROME; ESOPHAGUS CANCER; FATIGUE; FEMALE; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HUMAN; INCIDENCE; LONGITUDINAL STUDY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTIPLE CYCLE TREATMENT; OBSERVATIONAL STUDY; PANCREAS CANCER; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SOCIAL ASPECT; STATISTICAL MODEL; VALIDATION PROCESS;

AGE FACTORS; ANTIEMETICS; ANTINEOPLASTIC AGENTS; ANXIETY; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MODELS, STATISTICAL; NAUSEA; NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS; VOMITING;

EID: 84884289721     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-1843-2     Document Type: Article

References (28)

1. Glaus A, Knipping C, Morant R, Bohme C, Lebert B, Beldermann F, Glawogger B, Ortega PF, Husler A, Deuson R (2004) Chemotherapy-induced nausea and vomiting in routine practice: a European perspective. Support Care Cancer 12:708-715
2. Molassiotis A, Saunders MP, Valle J, Wilson G, Lorigan P, Wardley A, Levine E, Cowan R, Loncaster J, Rittenberg C (2008) A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre. Support Care Cancer 16(2):201-208
3. Molassiotis A, Farrell C, Bourne K, Brearley SG, Pilling M (2012) An exploratory study to clarify the cluster of symptoms predictive of chemotherapy-induced nausea using random forest modelling. J Pain Symptom Manage 44(5):692-703
4. Sun CC, Bodurka DC, Weaver CB et al (2005) Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer. Support Care Cancer 13:219-227
5. Osoba D, Zee B, Warr D et al (1997) Effect of postchemotherapy nausea and vomiting on health-related quality of life. Support Care Cancer 5:307-313
6. Rusthoven JJ, Osoba D, Butts CA et al (1998) The impact of postchemotherapy nausea and vomiting on quality of life after moderately emetogenic chemotherapy. Support Care Cancer 6:389-395
7. Farrell C, Brearley SG, Pilling M, Molassiotis A. The impact of chemotherapy-induced nausea on patients' nutritional status, psychological distress and quality of life. (accepted for publication, subject to minor corrections).
8. Molassiotis A, Stricker CT, Eaby B, Velders L, Coventry PA (2008) Understanding the concept of chemotherapy-related nausea: the patient experience. Eur J Cancer Care 17:444-453
9. Molassiotis A, Brearley SG, Stamataki Z (2011) Use of antiemetics in the management of chemotherapy-related nausea and vomiting in current UK practice. Support Care Cancer 19(7):949-956
10. Aapro M, Molassiotis A, Dicato M, Peláez I, Rodríguez- Lescure A, Pastorelli D, Ma L, Burke T, Gu A, Gascon P, Roila F; on behalf of the PEER investigators. The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER). Ann Oncol 2012. [Epub ahead of print].
11. Molassiotis A, Yam BM, Yung H, Chan FY, Mok TS (2002) Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patients. Support Care Cancer 10(2):139-145
12. Pirri C, Katris P, Trotter J, Bayliss E, Bennett R, Drummond P (2011) Risk factors at pretreatment predicting treatment-induced nausea and vomiting in Australian cancer patients: a prospective, longitudinal, observational study. Support Care Cancer 19(10):1549-1563
13. Warr DG, Street JC, Carides AD (2011) Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin-cyclophosphamide-based chemotherapy. Support Care Cancer 19(6):807-813
14. Dranitsaris G, Joy A, Young S, Clemons M, Callaghan W, Petrella T (2009) Identifying patients at high risk for nausea and vomiting after chemotherapy: the development of a practical prediction tool. I. Acute nausea and vomiting. J Support Oncol 7:W1-W8
15. Petrella T, Clemons M, Joy A, Young S, Callaghan W, Dranitsaris G (2009) Identifying patients at high risk for nausea and vomiting after chemotherapy: the development of a practical validated prediction tool. II. Delayed nausea and vomiting. J Support Oncol 7:W9-W16
16. Nunnally JC (1978) Psychometric theory. McGraw-Hill, New York
17. Roila F, Hesketh PJ, Herrstedt J (2006) Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer. Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference. Ann Oncol 17:20-28
18. Roscoe JA, Bushunow P, Morrow GR et al (2004) Patient expectation is a strong predictor of severe nausea after chemotherapy: a University of Rochester Community Clinical Oncology Program study of patients with breast carcinoma. Cancer 101:2701-2708
19. Montgomery GH, Bovbjerg DH (2000) Pre-infusion expectations predict post-treatment nausea during repeated adjuvant chemotherapy infusions for breast cancer. Br J Health Psychol 5:105-119
20. Spielberger CD, Lushene RE. State trait anxiety inventory test manual. P.A.C.P Press. 1983.
21. McCorkle R, Young K (1978) The development of a symptom distress scale. Cancer Nurs 1(5):373-378
22. Molassiotis A, Coventry PA, Stricker CT, Clements C, Eaby B, Velders L, Rittenberg C, Gralla RJ (2007) Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC antiemesis tool. J Pain Symptom Manage 34(2):148-159
23. Royston P (2005) Multiple imputation of missing values: Update of ice. Stata J 5(4):527-536
24. Chatterjee S, Hadi AS (2006) Regression analysis by example, 4th edn. Wiley, Hoboken
25. Hesketh PJ, Aapro M, Street JC, Carides AD (2010) Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy. Support Care Cancer 18(9):1171-1177
26. Shih V, Wan HS, Chan A (2009) Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide. Ann Pharmacother 43(3):444-452
27. Koffman J, Higginson IJ, Donaldson N (2003) Symptom severity in advanced cancer, assessed in two ethnic groups by interviews with bereaved family members and friends. J R Soc Med 96(1):10-6
28. Xu L, Koch KL, Summy-Long J, Stern RM, Seaton JF (1993) Hypothalamic and gastric myoelectrical responses during vection-induced nausea in healthy Chinese subjects. Am J Physiol 265:E578-584